My last post was a reminder that the Clean Development Mechanism(CDM) remains a miserable failure. The evidence that it does not actually contribute to solving the climate crisis included data that ...
Company now enrolling patients at leading research centers in Canada as well as in the United States LONDON, May 17, 2021 /PRNewswire/ -- AMO Pharma Limited ("AMO Pharma"), a privately held ...
- Company has achieved 50 percent of target enrollment in global Phase 3 trial The REACH-CDM trial will enroll a total of 56 patients. Upon completion of the trial, patients will have the opportunity ...
LONDON, May 17, 2021 /PRNewswire/ -- AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare, childhood-onset neurogenetic disorders with limited or no treatment ...
LONDON, Dec. 6, 2022 /PRNewswire/ -- AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare childhood-onset neurogenetic disorders with limited or no treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback